Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma
From Merck & Co., Inc.
Via Business Wire
Tickers MRK
LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian cancer without tumor BRCA mutations in the DUO-O Phase III trial
From AstraZeneca
Via Business Wire
Tickers AZN
Author Peter Zeihan on China, Apple, an Aging Population, and More
Via The Motley Fool
Tickers AAPL
Canoo Is About to Do Something It's Never Done Before!
Via The Motley Fool
Tickers GOEV
Workers: You Could Be Leaving $218,000 In Retirement Savings On the Table
Via The Motley Fool
Where Will Veeva Systems Stock Be in 1 Year?
Via The Motley Fool
Tickers VEEV
NCLA’s King George III Award Recognizes Atty. General Garland as Worst Violator of Civil Liberties
From New Civil Liberties Alliance
Via GlobeNewswire
Stay Away From This Red-Hot AI Stock
Via The Motley Fool
Tickers AI
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
Via The Motley Fool
Tickers AMZN DXCM VRTX
Two Compelling Reasons to Invest in Ethereum Today
Via The Motley Fool
Indianapolis, IN Author Publishes Book on the Endongo, the National Instrument of the Baganda People of Uganda
Via PR Leap
Altria Stock: Buy, Sell, or Hold?
Via The Motley Fool
Tickers MO PM
Nvidia's AI Demand Is Off The Charts. Is the Stock a Buy?
Via The Motley Fool
Tickers NVDA
Malaysian Stock: YTL Corporation Berhad
Via Talk Markets
3 Spectacular Stocks Down Between 30% and 88% That Should Soar in a Bull Market
Via The Motley Fool
Tickers AMZN HD ROKU
Financial Investment Analysis Expert LIU Antong: Developing the Future of the Industry with Professionalism
Via World Newswire
Topics Artificial Intelligence Bonds Economy
Exposures Artificial Intelligence Debt Markets Economy
SEO for Dentists: The Ultimate Guide to Attracting More Patients Online
Via Syndication Cloud
3 Dividend-Paying Tech Stocks to Buy in June
Via The Motley Fool
Tickers EQIX MSFT TSM
Growth Stocks Look Primed for a Rally. Is It Time to Jump Back In?
Via The Motley Fool
Tickers AMZN KO MRNA PTON
2 Types of Mortgages to Steer Clear Of
Via The Motley Fool
Tech Companies Have Lots of News for Their Investors
Via The Motley Fool
Tickers AMD AMZN ANF COST
CGTN: ‘A new culture for our times’: China eyes further advancement in cultural prosperity
Via TimesNewswire
2 Ultra-High-Yield Warren Buffett Dividend Stocks That Are Screaming Buys in June
Via The Motley Fool
Tickers VTS VZ
Support and Protect LGBTQ+
Via TimesNewswire
Topics LGBTQ Religion
Exposures Diversity Religion
Must-Have Gardening Tools and Gear for the Avid Gardener
Via Syndication Cloud
A.I. Certified Agents™ from Around the World Meetup to Create a Better Home Selling Experience
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
I Sold My Home for 8% More Than I Paid for It. Here's Why I Didn't End up Making Much of a Profit
Via The Motley Fool
4 Surprising Things About Sam's Club Member's Mark Products
Via The Motley Fool
Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting
From Castle Biosciences Inc.
Via Business Wire
Tickers CSTL
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
From Immunocore Holdings Limited
Via GlobeNewswire
Tickers IMCR
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.